November 19, 2021

The U.S. FDA has expanded emergency use authorization (EUA) for the Pfizer/BioNTech and Moderna COVID-19 vaccines. They can now be used to administer a booster dose to all U.S. adults who have completed primary vaccination with any FDA-authorized or approved COVID-19 vaccine.

  • Adults who received the Pfizer/BioNTech or Moderna vaccine for primary vaccination can receive a booster dose of either product at least six months after completing primary vaccination.
  • Adults who received the Janssen (Johnson & Johnson) vaccine for primary vaccination can receive a Pfizer/BioNTech or Moderna booster at least two months after receiving the Janssen vaccine.
  • Under the EUA, individuals do not have to receive the same brand of vaccine for their booster dose as they received for their primary vaccination series.
July 31, 2022

Brand Medications with Generic Alternatives Anticipated to be Approved in August

Read More
July 19, 2022

FDA Approves First Therapy for Repigmentation in Vitiligo

Read More
July 15, 2022

Zonisade Approved to Treat Seizures

Read More
July 14, 2022

Xalkori Granted New Indication to Treat Non-Cancerous Tumors

Read More